May 7, 2020 04:15PM
May 6, 2020 08:19AM
May 6, 2020 08:15AM
Apr 28, 2020 08:16AM
Apr 28, 2020 08:15AM
Apr 22, 2020 08:30AM
Apr 1, 2020 08:15AM Trovagene Announces Acceptance of Phase 1b/2 KRAS-Mutated Metastatic Colorectal Cancer (mCRC) Trial Abstract for Presentation at the 2020 ASCO Annual Meeting
Mar 5, 2020 08:15AM
Feb 27, 2020 04:15PM
Feb 13, 2020 08:07AM
Feb 13, 2020 08:00AM
Feb 5, 2020 08:00AM
Jan 29, 2020 08:08AM
Jan 29, 2020 08:00AM Trovagene Receives Approximately $1.45 Million From Exercise of Warrants
Jan 27, 2020 08:09AM
Jan 27, 2020 08:00AM
Jan 21, 2020 08:00AM
Dec 9, 2019 08:05AM
Dec 9, 2019 08:00AM
Dec 4, 2019 08:03AM
Dec 4, 2019 08:00AM Trovagene Announces Data Showing Ability of Onvansertib to Rescue Venetoclax-Resistance in Acute Myeloid Leukemia (AML)
Nov 14, 2019 08:00AM
Nov 14, 2019 08:00AM
Nov 7, 2019 04:20PM
Nov 6, 2019 09:00AM
Oct 25, 2019 01:39PM
Oct 25, 2019 01:37PM
Oct 22, 2019 08:26AM Trovagene (TROV) Announces Positive Response to Treatment in Phase 1b/2 Trial of Onvansertib in Patients with KRAS-mCRC
Oct 22, 2019 08:15AM
Oct 2, 2019 08:17AM
Oct 2, 2019 08:15AM
Oct 1, 2019 08:15AM
Sep 30, 2019 08:16AM
Sep 30, 2019 08:15AM
Sep 19, 2019 08:19AM Trovagene (TROV) Reports Complete Phase 1b Trial of Onvansertib in AML; Commences Patient Enrollment in Phase 2
Sep 19, 2019 08:15AM
Aug 26, 2019 08:03AM
Aug 26, 2019 08:00AM
Aug 8, 2019 04:15PM
Jul 22, 2019 08:30AM
Jul 15, 2019 08:30AM
Jul 9, 2019 08:05AM Trovagene (TROV) Commences Enrollment for Phase 1b/2 Clinical Trial in KRAS-Mutated Colorectal Cancer
Jul 9, 2019 08:00AM
May 30, 2019 05:50PM
May 23, 2019 08:06AM
May 23, 2019 08:00AM
May 13, 2019 08:05AM
May 13, 2019 08:00AM
May 7, 2019 04:20PM Trovagene Announces First Quarter 2019 Results and Highlights
Apr 23, 2019 08:03AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All